WallStreetZenWallStreetZen

NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Corbus Pharmaceuticals Holdings earnings were -$50.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CRBP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$17.0M, up 78.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRBP reported annual earnings of -$40.2M, with -9.9% growth.

CRBP earnings history

Current Revenue
$0.0
Current Earnings
-$50.3M
Current Profit Margin
0%

CRBP Return on Equity

Current Company
-36.9%
Current Industry
-59.8%
Current Market
29%
CRBP's Return on Equity (-36.9%)... subscribe to Premium to read more.
High Return on Equity Performance

CRBP undefined

Current Company
-32.9%
Current Industry
0.1%
CRBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRBP announces earnings.

CRBP undefined

Current Company
-38.39%
Current Industry
7.9%
CRBP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRBP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRBP-$48.74M-$50.29MN/A-$4.20
IMUX-$100.37M-$100.51MN/A-$1.00
SAVA-$71.75M-$72.79MN/A-$1.53
ZNTL-$164.37M-$165.84MN/A-$2.33
XBIT-$36.01M-$38.53MN/A-$1.26
View Top Biotech Stocks

Corbus Pharmaceuticals Holdings Earnings Reports & History FAQ

What were Corbus Pharmaceuticals Holdings's earnings last quarter?

On CRBP's earnings call on Invalid Date, Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) reported Q1 2025 earnings per share (EPS) of -$1.39, up 67.47% year over year. Total CRBP earnings for the quarter were -$16.98 million. In the same quarter last year, Corbus Pharmaceuticals Holdings's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.

Is Corbus Pharmaceuticals Holdings profitable or losing money?

As of the last Corbus Pharmaceuticals Holdings earnings report, Corbus Pharmaceuticals Holdings is currently losing money. Corbus Pharmaceuticals Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$50.29 million, a 48.97% increase year over year.

What was CRBP's earnings growth in the past year?

As of Corbus Pharmaceuticals Holdings's earnings date in Invalid Date, Corbus Pharmaceuticals Holdings's earnings has grown year over year. CRBP earnings in the past year totalled -$50.29 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.